First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution | Zendy

Daniël M. Jonker | Zendy; Manuela C. Koch | Zendy; Per Larsson | Zendy; Arjun Ravi | Zendy; Birgitte Buur Rasmussen | Zendy; Runa Speer | Zendy; Bernadette Mannaerts | Zendy

Open Access

First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution

Author(s) -

Daniël M. Jonker,

Manuela C. Koch,

Per Larsson,

Arjun Ravi,

Birgitte Buur Rasmussen,

Runa Speer,

Bernadette Mannaerts

Publication year - 2021

Publication title -

international journal of clinical pharmacology and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.363

H-Index - 67

ISSN - 0946-1965

DOI - 10.5414/cp204040

Subject(s) - bioequivalence , cmax , crossover study , pharmacokinetics , menotropins , geometric mean , follicle stimulating hormone , gonadotropin , confidence interval , pharmacology , medicine , endocrinology , adverse effect , ovulation , hormone , luteinizing hormone , ovulation induction , mathematics , statistics , alternative medicine , pathology , placebo

To determine whether serum human follicle-stimulating hormone (FSH) levels after single subcutaneous dosing of highly purified human menopausal gonadotropins (HP-hMG) in a liquid formulation and a powder formulation are bioequivalent.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research